Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Milademetan |
| Trade Name | |
| Synonyms | DS-3032b|Milademetan Tosylate|DS3032b|DS 3032b|RAIN-32 |
| Drug Descriptions |
Milademetan binds to MDM2 and prevents binding to p53, resulting in activation of p53 signaling and increased tumor cell apoptosis (PMID: 29416773, PMID: 32651541). |
| DrugClasses | MDM2 Inhibitor 23 |
| CAS Registry Number | 1398569-75-9 |
| NCIT ID | C107384 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cytarabine + Milademetan | Cytarabine Milademetan | 0 | 1 |
| Cytarabine + Milademetan + Venetoclax | Cytarabine Milademetan Venetoclax | 0 | 1 |
| Fulvestrant + Milademetan | Fulvestrant Milademetan | 0 | 1 |
| Milademetan | Milademetan | 0 | 5 |
| Milademetan + Osimertinib | Milademetan Osimertinib | 0 | 0 |
| Milademetan + Quizartinib | Milademetan Quizartinib | 2 | 1 |
| Milademetan + Selpercatinib | Milademetan Selpercatinib | 0 | 0 |
| Milademetan + Trametinib | Milademetan Trametinib | 0 | 0 |